The evidence behind the recommendations for complete revascularization (CR) in patients with ST elevation myocardial infarction (STEMI) and cardiogenic shock (CS), is scarce and is primarily based on the "Shock trial".
We sought to determine the event rates of the two treatment approaches- CR vs. culprit artery only (CAO) revascularization in patients presenting with STEMI and CS.
Methods: We analyzed a total of 180 consecutive patients presenting with STEMI and CS between 2001 and 2013. Patients were allocated into two groups based on the mode of revascularization. 81 patients underwent CAO-percutaneous coronary intervention (PCI) and 99 patients underwent PCI of all arteries with significant stenoses (≥70%). Outcome parameters included one month death, MI and stent thrombosis (ST) and six months death, target vessel revascularization (TVR), ST, and major adverse cardiovascular events (MACE).
:Results
